Catalysts for Macleods Pharmaceuticals Ltd
104 tracked
Apr 7, 2026
approval
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE (EMTRICITABINE) — FDA approval
emtricitabine
→
Apr 6, 2026
approval
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approval
DAPAGLIFLOZIN
→
Apr 6, 2026
approval
DAPAGLIFLOZIN — FDA approval
DAPAGLIFLOZIN
→
Mar 23, 2026
approval
MEXILETINE HYDROCHLORIDE — FDA approval
MEXILETINE HYDROCHLORIDE
→
Mar 2, 2026
approval
MOXIFLOXACIN HYDROCHLORIDE — FDA approval
MOXIFLOXACIN HYDROCHLORIDE
→
Feb 27, 2026
approval
DILTIAZEM HYDROCHLORIDE — FDA approval
DILTIAZEM HYDROCHLORIDE
→
Feb 17, 2026
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Feb 13, 2026
approval
COLCHICINE — FDA approval
COLCHICINE
→
Feb 3, 2026
approval
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Jan 21, 2026
approval
FENOFIBRATE — FDA approval
FENOFIBRATE
→
Jan 15, 2026
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Macleods Pharmaceuticals Ltd
→
Jan 6, 2026
approval
OLANZAPINE — FDA approval
olanzapine ODT
→
Dec 29, 2025
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 29, 2025
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Dec 29, 2025
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Dec 15, 2025
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 9, 2025
approval
DOXYCYCLINE HYCLATE — FDA approval
DOXYCYCLINE HYCLATE
→
Nov 25, 2025
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Nov 25, 2025
approval
IRBESARTAN — FDA approval
IRBESARTAN
→
Nov 19, 2025
approval
DOXYCYCLINE HYCLATE — FDA approval
DOXYCYCLINE HYCLATE
→
Oct 28, 2025
approval
TICAGRELOR — FDA approval
TICAGRELOR
→
Sep 30, 2025
approval
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Sep 30, 2025
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Macleods Pharmaceuticals Ltd
→
Sep 23, 2025
approval
LABETALOL HYDROCHLORIDE — FDA approval
LABETALOL HYDROCHLORIDE
→
May 6, 2025
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Jan 31, 2025
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Oct 31, 2024
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 31, 2024
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Oct 8, 2024
approval
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Dec 15, 2023
approval
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→